BioBay Investor Forum 2010

Suzhou

The Third Annual BioBay Investor Forum in Suzhou, presented by ChinaBio^®, is a two-day event bringing together investors and early stage life science companies at BioBay, the fastest growing life science park in China. Up to 20 companies will be presenting their technologies to over 200 attendees, including more than 50 VCs and investors. This will be the sixth Investor Forum and eight event ChinaBio^® Accelerator has organized in China. These events have raised over $350M for early stage companies in China.

From Cage to Clinic: Primate Research for Regenerative Medicine

Kunming, China

With the development of China’s biomedical research in non-human primate, the International NHP Research Symposium “From Cage to Clinic” has been highly successful and well-attended since 2004. More than 200 participants took part in the previous event in 2008. Building on the success of the previous meetings, the Symposium 2010 will be organized by and held at the National Engineering Research Center of Biomedicine and Animal Science in Kunming, Yunnan. It is hoped that this year's Symposium will make even greater progress and stimulate more discussions and research on nonhuman primate research for regenerative medicine.

BioPharm America™ 2010

Boston, MA, USA

BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe and BIO-Europe Spring®.

In 2009, the second edition of the event hosted some of the biggest names in biotech business who tackle many of the key issues on the minds of industry executives around the world. 700 attendees, representing 430 companies, participated in 1,550+ scheduled one-to-one meetings.

CHINA PRETRIALS 2010: Global Preclinical Development Summit

Beijing, China

Is China ready for GLP-compliant preclinical studies? Will the FDA and EMEA accept China data for IND approvals? CHINA PRETRIALS 2010 is the first-ever event that brings together the leaders in China's fast-growing preclinical development industry to fully answer these questions. Meet with and learn from hundreds of your peers from Western biotechs who have successfully outsourced to China, multinational and local pharma who are currently doing preclinical studies in China, and all the leading Chinese preclinical CROs and determine how China’s new capabilities can help your company bring innovative new medicines to the clinical stage faster and more efficiently.

CHINA TRIALS 2010

Beijing, China

The annual CHINATRIALS Summit has established itself as the must-attend industry-focused event for global clinical development executives in China. Over 100 speakers from leading pharmaceutical and biotech companies will share their latest insights for successfully conducting clinical trials in China. You will take away critical new information to apply to your business immediately. You will meet hundreds of new contacts as you network with over 400 of your global clinical peers. CHINATRIALS draws the highest ratio of pharmaceutical/biotech attendees of any Asia-focused clinical development conference and is the only clinical event you need to attend this year to stay updated on China’s fast-moving clinical development industry.

BIO-Europe 2010

Munich, Germany

BIO-Europe has grown into the premier industry event for getting deals started. The 15th edition of BIO-Europe established new standards in partnering productivity in Vienna, November 2009, with 2,500 international biotech and pharma leaders engaging in an astounding 12,504 one-to-one partnering meetings scheduled with partneringONE®.

BIO-Europe is the largest stand-alone partnering conference for the life sciences. Year after year, BIO-Europe attracts leading dealmakers from biotech, pharma and finance along with the most promising start-ups. Produced with the support of BIO, it is regarded as a “must attend” event for the biotech industry.